Women's Health Innovation Summit 2024

Championing Research: Investing & Partnering in Early-Stage Discovery

Improving the benchmark for measuring disease modification and reducing the use of symptomology is imperative for addressing underserved areas in women’s health such as ovarian cancer and endometriosis. This panel discussion will deep dive into the importance of prioritizing research through a sex & gender lens to identify new molecules, exploring the challenges and opportunities in investing in early-stage research, partnering with research institutions, and considering what more can be done.

Author:

Oriana Papin-Zoghbi

CEO & Co-Founder

AOA Dx

Author:

Sandy Milligan, MD, JD

Head of Research & Development

Organon

Author:

Primavera Spagnolo, MD, PhD

Scientific Director, Connors Center for Women’s Health and Gender Biology

Brigham and Women’s Hospital

At the Heart of the Issue: Precise, Personalized and Preventative Care to Improve Women’s Cardiovascular Health

According to the American Heart Association, nearly 75% of coronary heart disease cases in women can be prevented. Identifying sex-specific
risk factors through personalized risk assessments is an important step in creating precise treatment options to improve heart health. Join this panel discussion to hear from those leading the way in reducing the number one death of women in the US.

Author:

Carolee Lee

Founder & CEO

WHAM (Women's Health Access Matters)

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

Author:

Suzanne Steinbaum

CEO & Founder

Heart-tech Health

Author:

Rachel Robinson

Chief Operating Officer

MassMedic

Sustained Drug-Eluting Dosage Forms in Women’s Health: Leveraging Patient Centric Delivery

This presentation will cover VitalDose’s role in patient centric delivery within Women’s Health, exploring how using the sustained release of single or multiple drugs can relieve patient burden in chronic diseases and provide a benefit to the formulation of small molecule API to larger molecule or complex therapeutics.

Author:

Brian Wilson

New Business Development Partner, Pharma and Medical Businesses

Celanese

Investment Strategies for Long Term Success

With more investment in women’s health than ever before, there are newer and more exciting opportunities for innovation, but it’s important to consider what types of investment will achieve the best ROI. Join this discussion to hear from a panel of experts about the investment strategies they’ve adopted, understand the innovation that’s exciting to them, and consider the key factors for long term financial success.